On October 29, the recall was classified as a class II recall by the FDA—a situation in which "use of, or exposure to, a violative product may cause temporary or medically reversible adverse health ...

Schwartz and Zagaria 21 reported that the injection of arsenic into animals resulted in considerable increase of urinary coproporphyrin III, of short duration. The literature is thus relatively ...